SRTS vs. NNOX, NYXH, SMTI, ZIMV, STIM, TCMD, SNWV, NVRO, DRTS, and SKIN
Should you be buying Sensus Healthcare stock or one of its competitors? The main competitors of Sensus Healthcare include Nano-X Imaging (NNOX), Nyxoah (NYXH), Sanara MedTech (SMTI), ZimVie (ZIMV), Neuronetics (STIM), Tactile Systems Technology (TCMD), SANUWAVE Health (SNWV), Nevro (NVRO), Alpha Tau Medical (DRTS), and Beauty Health (SKIN). These companies are all part of the "medical equipment" industry.
Sensus Healthcare vs. Its Competitors
Sensus Healthcare (NASDAQ:SRTS) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, community ranking, profitability, media sentiment, earnings, risk and valuation.
Sensus Healthcare has a net margin of 15.90% compared to Nano-X Imaging's net margin of -465.38%. Sensus Healthcare's return on equity of 12.60% beat Nano-X Imaging's return on equity.
Sensus Healthcare received 150 more outperform votes than Nano-X Imaging when rated by MarketBeat users. However, 75.51% of users gave Nano-X Imaging an outperform vote while only 68.75% of users gave Sensus Healthcare an outperform vote.
Sensus Healthcare has a beta of 1.32, indicating that its share price is 32% more volatile than the S&P 500. Comparatively, Nano-X Imaging has a beta of 1.99, indicating that its share price is 99% more volatile than the S&P 500.
In the previous week, Nano-X Imaging had 3 more articles in the media than Sensus Healthcare. MarketBeat recorded 8 mentions for Nano-X Imaging and 5 mentions for Sensus Healthcare. Sensus Healthcare's average media sentiment score of 1.29 beat Nano-X Imaging's score of 0.61 indicating that Sensus Healthcare is being referred to more favorably in the media.
Sensus Healthcare presently has a consensus price target of $11.67, suggesting a potential upside of 134.74%. Nano-X Imaging has a consensus price target of $9.50, suggesting a potential upside of 84.11%. Given Sensus Healthcare's stronger consensus rating and higher probable upside, research analysts plainly believe Sensus Healthcare is more favorable than Nano-X Imaging.
Sensus Healthcare has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.
25.3% of Sensus Healthcare shares are held by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are held by institutional investors. 8.9% of Sensus Healthcare shares are held by company insiders. Comparatively, 7.7% of Nano-X Imaging shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Summary
Sensus Healthcare beats Nano-X Imaging on 14 of the 18 factors compared between the two stocks.
Get Sensus Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for SRTS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Sensus Healthcare Competitors List
Related Companies and Tools
This page (NASDAQ:SRTS) was last updated on 6/12/2025 by MarketBeat.com Staff
Buy SRTS Stock Free SRTS Stock Alerts